Managing Febrile Neutropenia: A Critical Oncologic Emergency Requiring Prompt Risk Stratification
**Lennox-Gastaut Syndrome (LGS)** is a profound and intractable form of childhood-onset epilepsy, classified as a severe developmental epileptic encephalopathy, characterized by a distinct clinical triad that makes it particularly challenging to manage. This triad includes **multiple types of seizures** (most notably tonic, atonic, and atypical absence seizures), a specific pattern on the **electroencephalogram (EEG)** known as slow spike-and-wave, and **intellectual disability** or developmental delay that often worsens over time. LGS is highly refractory to standard anti-seizure medications, necessitating a comprehensive, multimodal approach to stabilize the condition.
The array of seizures in LGS is a defining feature, and the diversity of seizure types contributes to the high risk of injury and cognitive decline. **Atonic seizures**, or 'drop attacks,' cause a sudden, brief loss of muscle tone, often resulting in sudden, unpredictable falls and recurrent injuries to the head and face. **Tonic seizures** involve sustained stiffening of the body, often occurring during…